A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma

The combination of gemcitabine and carboplatin is active and feasible in platinum-sensitive patients with recurrent ovarian cancer. This regimen is undergoing further evaluation in a large phase III trial.